427 related articles for article (PubMed ID: 32477261)
1. Causes and Consequences of Hypertriglyceridemia.
Packard CJ; Boren J; Taskinen MR
Front Endocrinol (Lausanne); 2020; 11():252. PubMed ID: 32477261
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.
Björnson E; Packard CJ; Adiels M; Andersson L; Matikainen N; Söderlund S; Kahri J; Hakkarainen A; Lundbom N; Lundbom J; Sihlbom C; Thorsell A; Zhou H; Taskinen MR; Borén J
J Intern Med; 2020 Oct; 288(4):422-438. PubMed ID: 31846520
[TBL] [Abstract][Full Text] [Related]
3. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.
Karpe F; Hellénius ML; Hamsten A
Metabolism; 1999 Mar; 48(3):301-7. PubMed ID: 10094104
[TBL] [Abstract][Full Text] [Related]
4. Triglyceride-Rich Lipoproteins.
Kockx M; Kritharides L
Cardiol Clin; 2018 May; 36(2):265-275. PubMed ID: 29609756
[TBL] [Abstract][Full Text] [Related]
5. [Hypertriglyceridemia: danger for the arteries].
Chanu B
Presse Med; 1999 Nov; 28(36):2011-7. PubMed ID: 10599270
[TBL] [Abstract][Full Text] [Related]
6. Model development to describe the heterogeneous kinetics of apolipoprotein B and triglyceride in hypertriglyceridemic subjects.
Barrett PH; Baker N; Nestel PJ
J Lipid Res; 1991 May; 32(5):743-62. PubMed ID: 2072038
[TBL] [Abstract][Full Text] [Related]
7. Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway.
Karpe F; Hultin M
J Lipid Res; 1995 Jul; 36(7):1557-66. PubMed ID: 7595079
[TBL] [Abstract][Full Text] [Related]
8. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
Tani S; Matsumoto M; Nagao K; Hirayama A
J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
[TBL] [Abstract][Full Text] [Related]
9. Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease.
Toth PP
Vasc Health Risk Manag; 2016; 12():171-83. PubMed ID: 27226718
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia.
Karpe F; Steiner G; Olivecrona T; Carlson LA; Hamsten A
J Clin Invest; 1993 Mar; 91(3):748-58. PubMed ID: 8450056
[TBL] [Abstract][Full Text] [Related]
11. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.
Walsh BW; Sacks FM
J Clin Invest; 1993 May; 91(5):2126-32. PubMed ID: 8486779
[TBL] [Abstract][Full Text] [Related]
12. Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase.
Xiang SQ; Cianflone K; Kalant D; Sniderman AD
J Lipid Res; 1999 Sep; 40(9):1655-63. PubMed ID: 10484612
[TBL] [Abstract][Full Text] [Related]
13. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
14. An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
Chan DC; Chen MM; Ooi EM; Watts GF
Int J Clin Pract; 2008 May; 62(5):799-809. PubMed ID: 18201179
[TBL] [Abstract][Full Text] [Related]
15. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
[TBL] [Abstract][Full Text] [Related]
16. The triglyceride connection in atherosclerosis.
Geurian K; Pinson JB; Weart CW
Ann Pharmacother; 1992 Sep; 26(9):1109-17. PubMed ID: 1421678
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities in lipoprotein metabolism in hemodialysis patients.
Königer M; Quaschning T; Wanner C; Schollmeyer P; Krämer-Guth A
Kidney Int Suppl; 1999 Jul; 71():S248-50. PubMed ID: 10412790
[TBL] [Abstract][Full Text] [Related]
18. Hypertriglyceridemia is exacerbated by slow lipolysis of triacylglycerol-rich lipoproteins in fed but not fasted streptozotocin diabetic rats.
Mamo JC; Hirano T; Sainsbury A; Fitzgerald AK; Redgrave TG
Biochim Biophys Acta; 1992 Oct; 1128(2-3):132-8. PubMed ID: 1420285
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
Oscarsson J; Hurt-Camejo E
Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
[TBL] [Abstract][Full Text] [Related]
20. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).
Hazzard WR; Bierman EL
Metabolism; 1976 Jul; 25(7):777-801. PubMed ID: 181657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
